RetinalGenix Technologies Inc.

RTGN · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$4,321-$2,091-$3,914-$2,179
Dep. & Amort.$1$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2,610$664$259$308
Change in WC$189$4$230$156
Other Non-Cash$779$1,074$3,225$548
Operating Cash Flow-$742-$348-$199-$1,167
Investing Activities
PP&E Inv.$0$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$0$0
Financing Activities
Debt Repay.$0$0$0$73
Stock Issued$503$1,090$61$1,083
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$245$348$134$14
Financing Cash Flow$748$348$195$1,170
Forex Effect$0$0$0$0
Net Chg. in Cash$6-$0-$5$3
Supplemental Information
Beg. Cash$0$0$5$2
End Cash$6$0$0$5
Free Cash Flow-$742-$348-$200-$1,167